Skip to main content
. 2019 Jul 22;14:1611–1631. doi: 10.2147/COPD.S184097

Figure 7.

Figure 7

Chitotriosidase levels in COPD subjects with low risk (GOLD category A+B) and high risk (GOLD category C+D) for future exacerbations.

Notes: Panels showing: chitotriosidase concentration (A) in peripheral blood, (B) in sputum; chitotriosidase activity (C) in peripheral blood, (D) in sputum; chitotriosidase mRNA expression (E) in peripheral blood, (F) in sputum. *P<0.05.

Abbreviation: PBMC, peripheral blood mononuclear cells.